250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical Device Startup Investors in Ireland

A list of 50 angel investors and VC funds that invest in Medical device startups based in Ireland. We rank investors based on the number of investments they made in Medical device companies from Ireland. We update this investor list every month.

Top 50 Medical Device Startup Investors in Ireland

Investor Medical Device Ireland investments
Enterprise Ireland 35
Western Development Commission 15
Atlantic Bridge University Fund 11
Irrus Investments 10
HBAN Medtech Syndicate 8
Enterprise Equity 7
EIT Health 6
Fountain Healthcare Partners 6
Elkstone Capital Partners 6
Furthr VC 6
Act Venture Capital 5
Atlantic Bridge 5
Delta Partners 4
EQT Life Sciences 4
AIB Seed Capital Fund 4
Business Venture Partners 4
Xenium Capital 4
Boole 4
Broadview Ventures 3
NDRC 3
Medtech Syndicate Nominee 3
Kernel Capital 2
Glanzmann Enterprises 2
Oyster Capital Partners 2
Ascentifi 2
European Investment Bank 2
Lightstone Ventures 2
Chip Hance 2
Cantor Fitzgerald 2
Boole Investment Syndicate 2
Partisan Management Group 2
Life Sciences Fund Amsterdam 2
Seroba Life Sciences 2
Mayo Clinic Ventures 2
COSIMO Ventures 1
Manatt Venture Fund 1
Nadav Ben-Chanoch 1
Sure Valley Ventures 1
Dublin Business Innovation Centre 1
Kreos Capital 1
The Foundry 1
Business Growth Fund 1
Invest Northern Ireland 1
Moffett Investment Holdings 1
Grimpeur Holdings 1
Quorndon Capital 1
Cliff Emmons 1
Crow Rock Capital 1
The University of Vermont Health Network 1
CAJU Venture Partners 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Enterprise Ireland VC Fund · Dublin, Dublin, Ireland · 15 investments in the past 12 months
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Funding Round, Seed, Series A
  • Ireland, United States, United Kingdom
Portfolio highlights
  • Nory AI — All of your restaurant operations managed in one platform, powered by AI. Tools that fuel better decision making and fatter profit margins.
  • Vertigenius — Vertigenius designs and deploys customized exercises using an easy-to-use clinician portal and even uses a Vertigenius head sensor to consult and manage patients with dizziness and imbalance.
  • Graphite Note — Create machine learning models with our no-code AI tool in minutes. Automatically transform data into key drivers, actionable insights, and strategic responses.
Western Development Commission VC Fund · Ballaghaderreen, Roscommon, Ireland · 2 investments in the past 12 months
Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Seed, Funding Round, Series A
  • Ireland, United States
Portfolio highlights
  • FeelTect — Connected health technology for disruptive improvements to wound care
  • CitySwift — CitySwift is a data-driven scheduling and planning technology for urban bus networks. It uses artificial intelligence and machine learning to predict journey times and passenger demand, making routes more efficient. Schedulers can create optimized timetables that take into account traffic, events, and hundreds of other external factors, ensuringon-time performance and increased passenger satisfaction.CitySwift was established in 2016 and is operating in Galway, Ireland.
  • Amara Therapeutics — Amara Therapeutics is passionate about empowering women and men to take control of their pelvic health. Amara Therapeutics use evidence based medicine and behavioural interventions supported by Amara Therapeutics platform of technologies to provide safe, convenient and non-invasive care pathways. At Amara Therapeutics mission is to fix the carepathway for pelvic health patients, connecting healthcare providers, patients and peers through our platform.
Atlantic Bridge University Fund VC Fund · Dublin, Dublin, Ireland
We invest in entrepreneurs with the ambition to create world-class companies of scale.
Show more
Investment focus
  • Medical Device, Health Care, Big Data
  • Seed, Series A, Funding Round
  • Ireland, United States
Portfolio highlights
  • CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
  • ProVerum Medical — ProVerum Medical is an early stage medical device startup for the treatment of Benign Prostatic Hyperplasia (BPH).
  • Tympany Medical — Tympany Medical is a Needs-driven, Innovative MedTech StartUp based in the West of Ireland
Irrus Investments VC Fund · Limerick, Limerick, Ireland · 2 investments in the past 12 months
Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.
Show more
Investment focus
  • Medical Device, Biotechnology, Health Care
  • Seed, Funding Round, Series A
  • Ireland, Sweden, United States
Portfolio highlights
  • FeelTect — Connected health technology for disruptive improvements to wound care
  • Bluedrop Medical — Evidence shows regular inspection of the feet can greatly reduce the risk of developing a diabetic foot ulcer (DFU).
  • SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
HBAN Medtech Syndicate VC Fund · 4 investments in the past 12 months
HBAN Medtech Syndicate
Show more
Investment focus
  • Medical Device, Medical, Health Care
  • Seed, Funding Round, Series B
  • Ireland
Portfolio highlights
  • FeelTect — Connected health technology for disruptive improvements to wound care
  • Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
  • SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
Enterprise Equity VC Fund · Dundalk, Louth, Ireland
Enterprise Equity (or EEVC) is an excellent for providing capital to early stage and expanding business throughout Ireland.
Show more
Investment focus
  • Software, Information Technology, Medical Device
  • Funding Round, Seed, Series B
  • Ireland, United States, United Kingdom
Portfolio highlights
  • Phorest — Join 8000+ spas, barbers, hair, beauty and nail salon owners using the #1 management, scheduling, POS and appointment booking system. Try Phorest now!
  • SurgaColl — SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien,the company aims to become a leader in the field of regenerative medical devices.
  • Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
EIT Health VC Fund · Munich, Bayern, Germany
EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.
Show more
Investment focus
  • Health Care, Medical Device, Medical
  • Grant, Pre-Seed, Seed
  • United Kingdom, Spain, Ireland
Portfolio highlights
  • Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
  • Trak — Do you know TRAK's tele rehabilitation software? Get more clinical performance and grow your physical therapy business, request a trial!
  • Nanordica Medical — Nanordica Medical develops novel nanoparticle-based antibacterial wound care products.
Fountain Healthcare Partners VC Fund · Dublin, Dublin, Ireland
Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Series C
  • Ireland, United States, France
Portfolio highlights
  • MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
  • Mainstay Medical — Mainstay Medical is improving quality of life for patients with chronic low back pain through innovative restorative treatment medical device solutions.
  • Ermium Therapeutics — Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases, based on a breakthrough discovery showing that CXCR4 is a master regulator of inflammation.
Elkstone Capital Partners VC Fund · Dublin, Dublin, Ireland · 10 investments in the past 12 months
Elkstone is an investment firm, focusing on entrepreneurs, senior executives, institutional LPs, the venture community, and the Irish diaspora.The objective of the organization is to boost the economic value and overall well-being of the island of Ireland by expanding a network, facilitating deserving investments, and delivering excellentinvestment performance.
Show more
Investment focus
  • Software, Health Care, Medical
  • Seed, Funding Round, Series A
  • Ireland, United Kingdom, United States
Portfolio highlights
  • Numra — Numra is an artificial intelligence automation for financial operations.
  • Jamango — Create and play for free in Jamango! Play with our block-based tools to make anything or explore a library of games and worlds instantly. No downloads.
  • Ori Industries — Ori is a developer of a cloud platform designed to enable computing anywhere and everywhere. It empowers developers and networks to build future applications for global infrastructure from smart cities, immersive worlds, and autonomous machines. Ori Industries was established in 2018 and is headquartered in London, England.
Furthr VC VC Fund · Dublin, Dublin, Ireland · 3 investments in the past 12 months
Furthr VC invests in transformative tech. Furthr Venture Capital invests in scalable, early-stage companies. We help Ireland's next generation of technology.
Show more
Investment focus
  • Medical, Medical Device, Health Care
  • Seed, Funding Round, Pre-Seed
  • Ireland
Portfolio highlights
  • GREYSCOUT — Need brand protection? Our best brand protection software monitors & removes unauthorized listings, helping businesses fight online counterfeiting.
  • Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
  • SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
Act Venture Capital VC Fund · Dublin, Dublin, Ireland · 5 investments in the past 12 months
Technology-focused, investing capital and expertise to fuel growth in the most promising ideas and companies. Raised c.€600m across multiple funds and invest from seed to growth.We look for companies with potentially cutting-edge, category-defining businesses in markets including application software, IT infrastructure, communications, Internetand mobile. We help founders create and scale businesses globally. We work as a small team with diverse strengths accessing a community of over 200 founders. The teams and companies we back scale their investor base as they scale their business execution and ambition. We work closely with them in this process. Over the past 25 years have built a broad network of US and European investors and founders that share our vision and approach.Act is based in Dublin, Ireland.Our most recent funds are supported by the European Investment Fund.
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Funding Round, Seed, Series A
  • Ireland, United States, United Kingdom
Portfolio highlights
  • CitySwift — CitySwift is a data-driven scheduling and planning technology for urban bus networks. It uses artificial intelligence and machine learning to predict journey times and passenger demand, making routes more efficient. Schedulers can create optimized timetables that take into account traffic, events, and hundreds of other external factors, ensuringon-time performance and increased passenger satisfaction.CitySwift was established in 2016 and is operating in Galway, Ireland.
  • GREYSCOUT — Need brand protection? Our best brand protection software monitors & removes unauthorized listings, helping businesses fight online counterfeiting.
  • Mavarick AI — Mavarick helps manufacturers to achieve sustainability and productivity breakthroughs with AI-driven Carbon Reporting, Machine Monitoring, OEE, Energy Management
Atlantic Bridge VC Fund · Dublin, Dublin, Ireland · 6 investments in the past 12 months
Atlantic Bridge is a Growth Equity Firm with a Cross Border Value Add strategy. We invest in deep technology companies in Europe and the US. Our team is made up of successful entrepreneurs and senior technology industry executives and we invest in strong ambitious entrepreneurs and management teams that have the passion and drive to scale up andexploit major growth opportunities. We help our portfolio companies expand and grow internationally through our global platform with our team and offices in London, Dublin, Munich, Paris and Palo Alto.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the UK and the US. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in Europe and the US. This approach is highly differentiated and has delivered strong performance results to date.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Series A, Series B, Funding Round
  • United States, Ireland, United Kingdom
Portfolio highlights
  • Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
  • Vertigenius — Vertigenius designs and deploys customized exercises using an easy-to-use clinician portal and even uses a Vertigenius head sensor to consult and manage patients with dizziness and imbalance.
  • Cambridge Mechatronics — Cambridge Mechatronics (CML) is a high technology design and engineering company based in Cambridge, UK. We specialise in pioneering and developing cutting-edge mechatronic platform technology from concept to mass production. We achieve this through technology licensing or partnerships with global manufacturing corporations. Our intellectualproperty portfolio consists of over 100 granted patents that we can exploit.
Delta Partners VC Fund · Leopardstown, Dublin, Ireland · 6 investments in the past 12 months
Early stage VC investments and funding for start-ups / founders in Ireland.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Seed, Series A
  • Ireland, United States, United Kingdom
Portfolio highlights
  • Jamango — Create and play for free in Jamango! Play with our block-based tools to make anything or explore a library of games and worlds instantly. No downloads.
  • inspeq ai — Inspeq AI uses metric-based evaluation and improves model performance, helps detect responses with low factual accuracy, and prevents them before serving to the end-users.
  • Offr — Offr is the new way to buy and sell property, quickly and transparently.
EQT Life Sciences VC Fund · Amsterdam, Noord-Holland, The Netherlands · 12 investments in the past 12 months
EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, The Netherlands, Switzerland
Portfolio highlights
  • Phagenesis — Phagenesis is developing a device for the treatment for dysphagia, the inability to swallow safely, that often accompanies stroke or other neuro-deficit diseases. The approach is to harness the brain's own capacity for relearning functions that have been lost through brain damage (via "neuroplasticity" or "corticalremapping"). Focusing initially on the care of stroke patients as they recover in hospital (acute care), Prof Shaheen Hamdy of the University of Manchester, UK, painstakingly devised a method of delivering electrical signals from the pharynx (throat) along nerve cells directly to the relevant parts of the brain. The results of his work have been published in top peer-reviewed scientific and medical journals, including The Lancet, the Nature group of publications, and Gastroenterology.
  • Onera Health — Introduction to Onera sleep diagnostics and monitoring solutions
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
AIB Seed Capital Fund VC Fund · Dublin, Dublin, Ireland
The AIB Seed Capital Fund was established in 2007 to provide venture capital for companies at the seed and early stages of development across a range of sectors throughout the Republic of Ireland. The Fund was established under the Enterprise Ireland Seed and Venture Capital Programme 2007-2012.The Fund has a total of €30m under managementwith AIB and Enterprise Ireland both committing €15m. It is managed by experienced managers with extensive expertise in making seed and early stage investments, adding value and facilitating business success.The Fund managers are empowered to make seed investments of up to approximately €500,000. Furthermore, the Fund has the capacity to make investments in later rounds to support the continued growth of investee companies.The Fund will be managed by Enterprise Equity Venture Capital and the Dublin Business Innovation Centre. This unique partnership brings together extensive regional and investment expertise.Enterprise Equity will evaluate and manage all investments outside the city and county of Dublin, as well as investments that require in excess of €250,000 from the fund within the city and county of Dublin.Dublin Business Innovation Centre (DBIC) will evaluate and manage all investments within the city and county of Dublin when the initial investment amount required from the Fund does not exceed €250,000.
Show more
Investment focus
  • Software, Health Care, Medical
  • Seed, Funding Round, Series A
  • Ireland, United States, Jersey
Portfolio highlights
  • NewsWhip — The only real-time media monitoring platform that predicts the stories and topics that will matter in the hours ahead.
  • Offr — Offr is the new way to buy and sell property, quickly and transparently.
  • Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Business Venture Partners VC Fund · Dublin, Dublin, Ireland · 3 investments in the past 12 months
Business Venture Partners was founded in 2004 as a corporate finance adviser for SME/owner managed businesses. The investment team is comprised of Elliott Griffin, Ronan Smith, Edel Coen and Mark Ruane and the team skills combine deep industry knowledge with experience in venture investing, corporate finance and international expansion. Theteam works on behalf of its clients buying and selling companies, raising finances, working with start-ups and advising on strategic growth, business succession and owner exits.Since 2007, BVP has successfully raised and managed 10 Simple Green BES and EII Funds. They have invested, on behalf of their investors, in some of Ireland’s most innovative companies such as Celtic Bioenergy, EFT Controls, and UrbanVolt. Our investment strategy is to spread investments over project finance and a portfolio of high potential companies. Their philosophy is to work hard with each investment to deliver valuable support for the company promoters and build shareholder value for their investors.In 2016 BVP launched The 10th BVP Green EII Fund. The fund provides eligible investors with the opportunity to avail of up to 40% income tax relief and provides the investor access to a portfolio of cleantech companies and renewable energy projects. The 11th Green Fund will be launched in Q4 2017.
Show more
Investment focus
  • Health Care, Information Technology, Medical
  • Seed, Funding Round, Series A
  • Ireland, Luxembourg, The Netherlands
Portfolio highlights
  • OOHPod — Self service parcel lockers for personal and business customers. Choose from a range of plans to suit you. Pay As You Go, Monthly and Premium Subscriptions available. Find your nearest OOHPod parcel locker and start using your out of home flexible address today.
  • Positive Carbon — Positive Carbon provides an innovative solution for businesses to track, manage, and reduce food waste. With real-time analytics, CO2 calculation, and a comprehensive learning platform, we help you save costs and achieve sustainability goals. Request a demo today to start making a positive environmental impact.
  • X-BOLT Orthapaedics — X-Bolt Trauma Solutions for osteoporotic bone fixation. FDA 510(k) approved. Clinical studies include the WHITE One (n=100) and WHITE Four (n=1,140) randomized control trials.
Xenium Capital VC Fund
Xenium Capital
Show more
Investment focus
  • Medical Device, Health Care, Biotechnology
  • Seed
  • Ireland
Portfolio highlights
  • Atrian Medical — AtriAN is commercializing technology created at Mayo Clinic in the US. AtriAN is an Irish Medical Device company based in Galway--A powerful and prolific hub for medical devices.AtriAN uses a gentle energy, micro Pulsed Electric Fields (mPEF) to only ablate hyperactivity. The other tissues such as the myocardium are spared.
  • ProVerum Medical — ProVerum Medical is an early stage medical device startup for the treatment of Benign Prostatic Hyperplasia (BPH).
  • Tympany Medical — Tympany Medical is a Needs-driven, Innovative MedTech StartUp based in the West of Ireland
Boole VC Fund
Boole
Show more
Investment focus
  • Medical Device, Health Care, Medical
  • Seed, Funding Round
  • Ireland
Portfolio highlights
  • Incereb — Lifelines Neuro offers exceptional infant EEG electrodes with Incereb. Learn more about this wonderful device for neonates in the NICU.
  • ProVerum Medical — ProVerum Medical is an early stage medical device startup for the treatment of Benign Prostatic Hyperplasia (BPH).
Broadview Ventures VC Fund · Boston, Massachusetts, United States
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Seed, Debt Financing
  • United States, Canada, Israel
Portfolio highlights
  • IsomAb — IsomAb evaluate and develop isoform specific antibodies to treat disease.
  • Nyra Medical — MitraPlug has created a catheter-plug technology for repairing a leaky mitral valve in the heart.This adjustable device needs only a two-inch surgical incision and can be inserted directly into the heart. Then the cardiologist can use the catheter to adjust the size and position of the plug to correct the leakage. When correctly fitted, thecatheter is removed, and the incision is closed, leaving only a small scar.
  • Cardiosense — Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease.
NDRC VC Fund · Dublin, Dublin, Ireland · 2 investments in the past 12 months
NDRC builds high-impact new ventures. By providing the people, time, space and investment needed at the earliest stages of dedicated commercialisation work, NDRC is creating companies worthy of commercial investment and with the ability to scale. The NDRC team has the breadth of knowledge and expertise in technology and markets. NDRC worksside-by-side with researchers, entrepreneurs and venture teams to turn great ideas into successful new ventures.By the end of 2014, NDRC’s portfolio of startup ventures had secured a cumulative €88m in follow-on investment from commercial investors, with a combined market capitalisation of approx. €220m.
Show more
Investment focus
  • Software, Information Technology, E-Commerce
  • Seed, Pre-Seed, Convertible Note
  • Ireland, United States, United Kingdom
Portfolio highlights
  • Nory AI — All of your restaurant operations managed in one platform, powered by AI. Tools that fuel better decision making and fatter profit margins.
  • Dataships — Dataships uses top level data privacy software to help your brand, no matter your location.
  • Ceartas DMCA — Ceartas is the leader in piracy protection for creators, brands & enterprise. Powered by AI, we have the highest removal rate in the industry
Medtech Syndicate Nominee VC Fund
Medtech Syndicate Nominee
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Seed, Series A, Funding Round
  • Ireland
Portfolio highlights
  • Kite Medical — Kite medical has developed a novel device for detecting Kidney Reflux in children with Urinary Tract Infections. The non-invasive diagnostic solution for kidney reflux removes the need for complicated procedures and a hospital visit. Kidney reflux is the most common urological disorder in childhood, affecting up to three per cent of young children.It is most prevalent from six months to five years of age. The condition may resolve as the child gets older, but left undiagnosed and untreated it can lead to permanent kidney damage and ultimately to kidney failure.
  • Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
Kernel Capital VC Fund · Cork, Cork, Ireland
Kernel Capital is the independent manager of The Bank of Ireland Kernel Capital Venture Funds, one of the largest and most active sources of equity finance on the island of Ireland. Kernel leverage their extensive network to enable their portfolio companies recruit the highest caliber people, to break into new international markets and to generaterevenues of scale. It is the only investment firm with venture capital Funds dedicated to both jurisdictions on the Island. Kernel have raised over €210M from investors which including their strategic partner Bank of Ireland, Invest NI, Enterprise Ireland, Galway University Foundation, The University of Limerick Foundation, The New York State Common Retirement Fund and undisclosed Family Offices. Consistently delivering strong financial returns for their investors Kernel have led more than 20 substantial trade sales to NASDAQ, NYSE, and LSE listed corporations.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Seed, Series A
  • Ireland, United Kingdom, France
Portfolio highlights
  • Pretto — Pretto is the only truly transparent online real estate price comparator.Pretto accompanies you until the signing of your loan, free of charge and without commitment.
  • Pilot Photonics — Welcome to Pilot Photonics, a laser product development company in Dublin, Ireland. We provide optical frequency combs and tunable lasers.
  • Causeway Sensors — The Affinity, is a compact, bench-top Biosensor providing accurate real-time analysis at an accessible price. The Affinity biosensor and accompanying Access Chip incorporate the latest advancements in Nanotechnology, providing the biochemistry researcher the perfect platform to explore the complex world of biomolecular interactions.
Glanzmann Enterprises VC Fund
Glanzmann Enterprises
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Series A, Funding Round
  • Ireland
Portfolio highlights
  • Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
Oyster Capital Partners VC Fund · Blackrock, Dublin, Ireland
Oyster Capital Partners, an Irish private equity firm, specializes in the energy technology, IT, and healthcare sectors.
Show more
Investment focus
  • Software, Medical Device, Enterprise Software
  • Series A, Funding Round, Seed
  • Ireland, United Kingdom, United States
Portfolio highlights
  • Inclusio — The inclusio diversity and inclusion platform is designed to measure and positively shift the culture of your organisation. Contact us for more information.
  • Ooodles — The service platform to get premium tech products for you, your business and your employees
  • &Open — For businesses that gift to give back, share joy, or show they care. All you need is an email.
Ascentifi VC Fund · Galway, Galway, Ireland · 2 investments in the past 12 months
Discover start-up investing made simple. Access VC-led rounds, build your portfolio, and unlock growth at Ascentifi
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Funding Round, Series A
  • Ireland
Portfolio highlights
  • Vertigenius — Vertigenius designs and deploys customized exercises using an easy-to-use clinician portal and even uses a Vertigenius head sensor to consult and manage patients with dizziness and imbalance.
  • Bluedrop Medical — Evidence shows regular inspection of the feet can greatly reduce the risk of developing a diabetic foot ulcer (DFU).
  • X-BOLT Orthapaedics — X-Bolt Trauma Solutions for osteoporotic bone fixation. FDA 510(k) approved. Clinical studies include the WHITE One (n=100) and WHITE Four (n=1,140) randomized control trials.
European Investment Bank VC Fund · Luxembourg, Luxembourg, Luxembourg · 25 investments in the past 12 months
European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Debt Financing, Post-IPO Debt, Funding Round
  • France, Germany, The Netherlands
Portfolio highlights
  • Eldrive — The largest charging point operator in Eastern Europe | Our network is expanding rapidly yet our focus is fixed on renewables, for a greener future. We provide AC & DC charging across Bulgaria, Romania and Lithuania.
  • ABN AMRO Bank — Als bank leggen wij de focus op inclusiviteit, duurzaamheid, sociaal ondernemen, innovatie, dagelijkse bankzaken en meer.
  • Enel Green Power — Enel Green Power is the company that deals with renewable energy from every perspective: from direct sales through PPA, to commitment at the forefront with its plants worldwide.
Lightstone Ventures VC Fund · Menlo Park, California, United States · 5 investments in the past 12 months
Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, Ireland, Singapore
Portfolio highlights
  • Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
  • Amber Therapeutics — Developing intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology
  • Reprieve Cardiovascular — Reprieve Cardiovascular is bringing intelligence to decongestion management to safely accelerate fluid removal for heart failure patients.
Chip Hance Angel
Chip Hance
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Series A, Funding Round
  • Ireland
Portfolio highlights
  • Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
Cantor Fitzgerald VC Fund · New York, New York, United States
Cantor Fitzgerald is a global financial services firm that specializes in equities, investment banking, and real estate, fixed income and currencies, prime services, and, affiliates. The firm is known for developing advanced technologies to expand market access, and help clients achieve their most important financial and strategic objectives. Thiscommitment to client-centered innovation has led to enduring relationships with many of the world’s most demanding institutional investors and corporations. The company was founded in 1945 and is headquartered in New York.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Post-IPO Equity, Series B, Series A
  • United States, Canada, Ireland
Portfolio highlights
  • Wejo — We unlock limitless possibilities with connected vehicle data
  • View — View is the leader in smart building technologies that transform buildings to improve human health and experience, reduce energy consumption and carbon emissions, and generate additional revenue for building owners. View Smart Windows use artificial intelligence to automatically adjust in response to the sun, increasing access to natural light andunobstructed views while eliminating the need for blinds and minimizing heat and glare. Every View installation includes a cloud-connected smart building platform that can be extended to reimagine the occupant experience. View is installed and designed into over 90 million square feet of buildings, including offices, hospitals, airports, educational facilities, hotels, and multifamily residences. For more information, please visit: www.view.com.
  • REIGO Investments — Reigo Investments is a technology company reshaping the real estate investment space. Focusing on the senior hard money lending US market, the company employs data science to improve performance, reduce defaults, and reduce underwriting time dramatically.
Boole Investment Syndicate VC Fund · Cork, Cork, Ireland · 2 investments in the past 12 months
Boole Investment Syndicate invests in new technology start-up's with scalability.
Show more
Investment focus
  • Medical Device, SaaS, EdTech
  • Seed, Funding Round
  • Ireland, United States
Portfolio highlights
  • FeelTect — Connected health technology for disruptive improvements to wound care
  • Hooke Bio — Hooke Bio is a new Pharmaceutical company operating in the preclinical to early stages of drug discovery. It draws its strength from the close co-operation it has between its biologists and engineers. The engineers design, patent and test new microfluidic technology: the scientists apply the technology to finding new therapeutics.
  • SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
Partisan Management Group VC Fund · Evergreen, Colorado, United States
Partisan Management Group is a highly successful, early stage venture capital investor in medical device companies.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Funding Round, Series A, Series B
  • United States, Ireland
Portfolio highlights
  • TriSalus Life Sciences — Surefire Medical, based in Westminster, Colorado, was founded in 2009 to develop a novel infusion system for the interventional radiology market. The Surefire's Infusion System is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter. Because of this differentiated expandable tip, whichcollapses in forwarding flow to maintain blood flow and dynamically expands to the vessel wall in reverse flow to minimize reflux, Surefire's Infusion System is designed to substantially reduce damage to healthy tissue.
  • Enable Injections — Enable Injections designs, manufactures, and sells wearable delivery devices for injectable drugs. The Enable Injections products can deliver drugs directly from standard vials supplied by all pharmaceutical companies, can reconstitute powdered drugs into liquids as a part of the injection procedure, can inject very viscous drugs, and can inject upto 20 ml. Such products are called bolus injection systems. No other existing drug delivery device can accomplish all of these tasks. Approximately 900 new drugs are being developed that may require bolus injection technology like that being developed by Enable Injections. The total market is expected to reach $8 billion within ten years. Partisan principals have supplied 10% of the seed capital to Enable Injections. It also delivers a controlled flow of up to 50 ml of a biologic through an automatically inserted needle. Enable Injections also offers a version of the drug delivery platform that may connect to smartphones via Bluetooth. It also utilizes any standard container closure system, including syringes or vials; automatically warms and can automatically mix lyophilized solutions.Enable Injections was founded in 2010 and is headquartered in Cincinnati, Ohio, USA.
  • Ponce De Leon Pharmaceuticals — Ponce De Leon Pharmaceuticals is a privately financed development stage company, committed to the extension of human health span, endeavoring to offer more healthy years of living. In conjunction with the Buck Institute for Research on Aging, the Company has developed a formulation comprised of GRAS (Generally Regarded As Safe) components. Thisformulation has been shown to radically increase mean lifespan in the invertebrate model (C. Elegan), well beyond any previously published data on drugs or compounds. Testing has now begun at the Buck Institute in the mammalian model (mouse), and the Company hopes to have a patent pending product available to the public at the conclusion of those studies, or in about three years.
Life Sciences Fund Amsterdam VC Fund · Amsterdam, Noord-Holland, The Netherlands
Life Sciences Fund Amsterdam is an independent venture capital fund aiming to capitalize on new technological developments in the life sciences sector. It provides investment capital to fund high tech entrepreneurial activity in the Amsterdam Metropolitan Area in general and at the academic medical centres in particular. The fund is a specialistt fund, targeting companies that are developing commercially promising products and technologies in life sciences, including: pharmaceuticals, biotechnology, medical devices and other high technology opportunities that offer venture capital returns. The Fund focuses on seed and early stage companies, but also on pre-seed commercially viable academic projects.The close collaboration between the fund, the technology transfer offices of the Life Sciences Centre Amsterdam and the Amsterdam Biomed Cluster, enables the fund to facilitate the transfer of technology to the private sector and to provide emerging technology companies and university researchers with vital seed funding and specialized financial and technical assistance. The fund started in 2007 and is now fully invested.
Show more
Investment focus
  • Medical Device, Medical, Communities
  • Series A, Funding Round, Private Equity
  • Ireland, The Netherlands
Portfolio highlights
  • Sigmascreening — At Sigmascreening, an Amsterdam based medical device company, they focus on the development of new products in the area of breast cancer screening. Sigmascreening is established as a spin-off company from the Academic Medical Center Amsterdam (AMC Amsterdam). They have several products under development, which are all aimed at improving digitalmammography, the “golden standard” in breast cancer screening.
  • Neurent Medical — Neurent Medical is dedicated to developing highly innovative non-surgical interventions that treat chronic inflammatory Sino-Nasal diseases.
Seroba Life Sciences VC Fund · Dublin, Dublin, Ireland · 2 investments in the past 12 months
Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Funding Round
  • Ireland, United States, United Kingdom
Portfolio highlights
  • Shorla Pharma — Shorla Pharma is an Irish specialty pharmaceutical company. It is growing portfolio brings accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical impact.
  • Storm Therapeutics — Targeting pathways that modify RNA to deliver novel cancer therapeutics.
  • Artica Therapeutics — Artica Therapeutics specializes in biotechnological research and development for medical devices, pharmaceutical processes, and food.
Mayo Clinic Ventures VC Fund · Rochester, Minnesota, United States
Mayo Clinic Ventures is dedicated to quickly bringing answers to the people who need them most: the patients living with diseases and conditions that threaten to limit or even end their lives. Our team works closely with Mayo physicians and scientists to mine inventions, ideas and discoveries that will truly transform health care. Their dedicatedefforts bring significant financial support to Mayo's patient care, education and research efforts.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Seed
  • United States, Ireland, China
Portfolio highlights
  • Turtle Health — Turtle Health is a virtual fertility counselling clinic. We provide you with personalized, medically meaningful information to help you plan your fertility journey, early and affordably.
  • The Patient Company — The Patient Company provides clinical staff members with an automated lateral patient transfer device called SimPull. The company was founded in 2019 by Andrew Heuerman and is based in Grand Rapids, Michigan.
  • Tympany Medical — Tympany Medical is a Needs-driven, Innovative MedTech StartUp based in the West of Ireland
COSIMO Ventures VC Fund · Dublin, Dublin, Ireland
COSIMO Ventures is an emerging venture capital firm that focuses on early stage companies seeking to develop disruptive technology, primarily located in Ireland and the United Kingdom. COSIMO has offices in Boston, Massachusetts and Dublin, Ireland. Our Team have over 100 years of combined entrepreneurial operating and investing experience. We aretechnology pioneers resolute in our mission of helping emerging entrepreneurs build legendary companies. Our mission is to help transform the most promising early stage, Irish and UK technology companies into global leaders that will dominate new market categories or disrupt existing ones. We partner with management teams to help them accelerate and grow into the US market.COSIMO is a team of entrepreneurs that have been at the forefront of value creation for early stage companies over the past 25 years. As technology pioneers, we have developed products used by 100’s of millions of users every day and created many firsts; from the first commercially available financial service on the Internet to the first push notification.
Show more
Investment focus
  • Enterprise Software, Blockchain, Sports
  • Seed, Series A, Funding Round
  • Japan, Ireland, United States
Portfolio highlights
  • Defactor — Defactor is a creator of integration and risk management platforms intended to create a link between centralized and decentralized finance. Their business uses the native token $FACTR and the Springpad platform, which upends the current centralized banking system and enables companies to manage assets, convert money from FIAT currencies with ease,gain visibility over digital assets despite having little experience with doing so, and access liquidity in decentralized finance. It is being used by Defactor to bring real-world assets to DeFi and unlock working capital for SMEs all over the world. The company's mission is to accelerate the adoption of decentralized finance and enable businesses all over the world to grow economically.
  • ICHI — Grow any token with low-slippage, on-chain liquidity
  • BEASY — BEASY Wallet & Forge makes it easy for collectors and creators to mint, buy, sell, trade, and manage their own NFTs. No crypto knowledge required!
Manatt Venture Fund VC Fund · Los Angeles, California, United States
The Manatt Venture Fund is the investment arm of Manatt, Phelps & Phillips, LLP, a Los Angeles-based law firm. The Fund makes early-stage investments, and since its founding in 2000 it has made investments in over 90 companies. The official investment entity is MPP Holdings, LLC.
Show more
Investment focus
  • Software, Mobile, Internet
  • Series A, Seed, Series B
  • United States, Ireland, United Kingdom
Portfolio highlights
  • Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
  • Kitterly — Kitterly sells knitting & crochet kits to make anything from accessories, clothing and dog sweaters.
  • Genome Medical — We are genetic experts who partner with healthcare organizations to deliver best-in-class genetic counseling services and bring precision medicine to more lives.
Nadav Ben-Chanoch Angel · Miami, Florida, United States · 14 investments in the past 12 months
Nadav Ben-Chanoch - Partner @ Pareto Holdings
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Pre-Seed, Funding Round
  • United States, United Kingdom, France
Portfolio highlights
  • Swaap — We build the market-neutral AMM protocol.
  • micro1 — We help companies hire and manage the best software engineers easily.
  • Skedway — Every work experience should be great! Skedway is the complete platform to optimize the hybrid work experience.
Sure Valley Ventures VC Fund · London, England, United Kingdom · 2 investments in the past 12 months
An entrepreneur led Venture Capital Fund that invests in early stage software companies. Working in partnership with Shard Capital, a specialist broker and asset manager based in the City of London, Sure Valley Ventures specialises in investing in Augmented Reality (AR) and Virtual Reality (VR), Financial Technology (FinTech), and the Internet ofThings (IoT) Sectors.
Show more
Investment focus
  • Software, Virtual Reality, Augmented Reality
  • Seed, Series A, Funding Round
  • Ireland, United Kingdom
Portfolio highlights
  • Jaid — Jaid is an artificial intelligence-powered platform that identifies and extracts critical data from various company and customer communications.
  • Everyangle — Everyangle facilitates business in computer vision applications based on cisco meraki MV smart cameras across retail and industrial firms.
  • Virtex Stadium — Take over the stadium with your friends and view the game live in 3D. You have never been closer to the game before! Join Virtex Stadium now and never miss the live show!
Dublin Business Innovation Centre VC Fund · Dublin, Dublin, Ireland
Furthr provides long-term support to startups and SME businesses in Ireland. We support Irish entrepreneurs who excel in innovation and international trading.
Show more
Investment focus
  • Software, Web Development, Analytics
  • Funding Round, Series A, Seed
  • Ireland, United States, Luxembourg
Portfolio highlights
  • NewsWhip — The only real-time media monitoring platform that predicts the stories and topics that will matter in the hours ahead.
  • CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
  • VideoElephant — VideoElephant offers ready-to-monetize video content solutions to advertising technology providers, publishers, and advertisers. Its online marketplace enables users to access a library of video contents comprising various short and long-form videos, such as TV shows, movies, documentaries, and short videos. the company was founded in 2012 and isheadquartered in Dublin.
Kreos Capital VC Fund · London, England, United Kingdom · 4 investments in the past 12 months
Kreos Capital is Europe's largest and leading provider of growth debt to high-growth companies with revenues up to €150 million. Since 1998, as the pioneer growth debt provider across the UK, Western Europe, Scandinavia and Israel: Kreos has completed nearly 450 transactions and committed €1.8 billion in 14 different countries. Kreos has aproven track record of adding value to portfolio companies and helping them to grow with additional capital and flexibility throughout their business cycle whilst working closely with both the portfolio company management team and their equity sponsors.The Kreos global team has extensive debt financing, management and equity investing experience, covering the pan-European market from its locations in London, Tel Aviv and Stockholm.Kreos is a value added partner, able to offer additional capital and more flexibility with lower equity dilution. Kreos's international team has extensive entrepreneurial, debt financing and equity investing experience, covering all local European markets from its locations in London, Tel Aviv and Stockholm.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Debt Financing, Series B, Post-IPO Debt
  • United Kingdom, Germany, United States
Portfolio highlights
  • Abivax — Abivax recently presented impressive 9-month interim extension data from studies of ABX464 in ulcerative colitis during an oral presentation at DDW 2019, demonstrating a continued duration of beneficial effect in patients after 11-months of treatment. View the conference presentation, here:
  • BiolineRx — BioLineRx is building a best-in-class pipeline designed to deliver meaningful therapeutic benefit to patients with certain cancers and rare diseases.
  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
The Foundry VC Fund · Menlo Park, California, United States
The Foundry, LLC is the premier medical device company incubator. We work with inventors to rapidly transform their concepts into companies by providing an incomparable combination of leadership, an experienced, multi-disciplinary team, a state-of-the-art facility and an extensive funding network. The Foundry Team is comprised of veteran medicaldevice entrepreneurs and investors with real world experience—and success—in developing world class medical device companies.
Show more
Investment focus
  • Health Care, Therapeutics, Biotechnology
  • Series A
  • Ireland
Portfolio highlights
  • FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
Business Growth Fund VC Fund · London, England, United Kingdom · 27 investments in the past 12 months
BGF invests in hundreds of businesses from an evergreen balance sheet. But we offer more than just growth capital. Find out what makes us different.
Show more
Investment focus
  • Software, Information Technology, Manufacturing
  • Funding Round, Series A, Private Equity
  • United Kingdom, Ireland, United States
Portfolio highlights
  • Avoca Clinic — The Avoca Clinic is Ireland's only plastic surgery clinic. Our World Class Consultants are all Irish Medical Council Registered. Book a free consultation today
  • Stellar Omada — Stellar Omada delivers leading business & digital transformation that exceeds expectations in a constantly changing world. Contact us.
  • Machine Discovery — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
Invest Northern Ireland VC Fund · Belfast, Belfast, United Kingdom
Invest Northern Ireland is Northern Ireland's economic development agency. Their overall goal is to help create wealth for the benefit of the whole community by strengthening the economy and helping it grow.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Funding Round, Grant, Seed
  • United Kingdom, United States, Ireland
Portfolio highlights
  • TruCorp — TruCorp: Your source for lifelike Medical Training Equipment. Explore our intubation manikins & airway trainers. Request a free demo today!
  • Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
  • CV6 Therapeutics — CV6 Therapeutics is a drug development company focused on the discovery, development and commercialization of novel therapies for the treatment of human diseases.
Moffett Investment Holdings VC Fund
Moffett Investment Holdings is an investment firm
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Series A, Series B
  • Ireland
Portfolio highlights
  • Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
Grimpeur Holdings VC Fund
Grimpeur Holdings is a venture capital investment firm.
Show more
Investment focus
  • Health Care, Medical Device, Health Diagnostics
  • Seed
  • Ireland
Portfolio highlights
Quorndon Capital VC Fund
Quorndon Capital is a Investment Firm.
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Series A
  • Ireland
Portfolio highlights
  • HealthBeacon — The World's Leading Digital Health Platform for Injectable Medications As many as 1-in-2 patients fail to adhere to their medication schedule. Our
Cliff Emmons Angel
Cliff Emmons is the Chief Executive Officer of Oxys.
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Seed
  • Ireland
Portfolio highlights
  • Gasgon Medical — Medical device start-up | Improving healthcare with advanced IV technology | Infused With Confidence | Cork, Ireland.
Crow Rock Capital VC Fund
Crow Rock Capital is an investment firm.
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Funding Round
  • Ireland
Portfolio highlights
  • HealthBeacon — Quality adherence support for your medication needs, contact our HealthBeacon team to discover what service we can provide you and your patients.
The University of Vermont Health Network VC Fund · Burlington, Vermont, United States
Welcome to The University of Vermont Health Network, five partner hospitals serving the residents of Vermont and northern New York. With over 4,000 health care providers throughout our region, they work together to offer high-quality care more cost-efficiently and as close to home as possible. Strengthened by their connection, each of theirhospitals remains committed to its local community and to the heart and science of medicine: compassionate, personal care shaped by the latest medical advances and delivered by highly skilled experts.
Show more
Investment focus
  • Medical, Biotechnology, Fashion
  • Seed, Series B, Funding Round
  • United States, Ireland
Portfolio highlights
  • BioFactura — BioFactura has developed the StableFast™ Biomanufacturing Platform, a novel system to rapidly generate stable NS0 cell lines for biopharmaceutical manufacturing. The elements of this system include a chemically-defined, serum- and cholesterol-free production medium and pre-adapted parental cells, modular expression vectors that utilize a patentedselection strategy, and a proprietary growth supplement that permits rapid generation and cloning of cell lines. This platform is simple to use, fast, and productive. A clonal production cell line can be developed and scaled up to yield over one gram of product in less than eight weeks.
  • THEYA Healthcare — Creators of the Post Surgery Bra proven to heal. Hypoallergenic and Antibacterial Underwear for Sensitive Skin, Post Partum, and Menopause using soft, safe & sustainable bamboo. Post-Op wear from labiaplasty recovery to stoma briefs. Mastectomy and breast cancer care specialists. Sizes XS to 4XL & Worldwide Shipping!
  • Veralox Therapeutics — Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.
CAJU Venture Partners VC Fund · Amsterdam, Noord-Holland, The Netherlands
Caju Venture Partners invests in MedTech in the European Union. Caju Venture Partners invests in entrepreneurs with high integrity who can establish great businesses and impact healthcare in the future.
Show more
Investment focus
  • Health Care, Medical Device
  • Funding Round
  • Ireland
Portfolio highlights
  • FeelTect — Connected health technology for disruptive improvements to wound care
Investors by industry
Investors by country
Investors in Ireland by industry